| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.089 | 0.2 |